GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of three years of 503A threads, summarised so you do not have to read them — 34 comments in the full submission. View in context.
4k
c/compounding·submitted 1 year ago by u/hassan_chowdhury

three years of 503A threads, summarised so you do not have to read them

Discussionbranch of 7 comments

Right, the API source question again, but with numbers this time. I have 9 data points over 40 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am…

Read the full submission and all 34 comments →

This branch

7 comments, started 1 year ago
u/nadia_fonseca153 points·1 year ago

Titration speed is a side-effect dial far more than an efficacy dial.

replysharereportpermalink
u/hassan_chowdhuryOP97 points·1 year ago

The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.

replysharereportpermalink
u/anya_antonsen35 points·1 year ago

Did they tell you their API source or dodge the question?

replysharereportpermalink
u/hassan_chowdhuryOP26 points·1 year ago

state board rules differ, say which state

replysharereportpermalink
u/tb500_tangent118 points·1 year ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/gallbladder_gary28 points·1 year ago

regulatory claims need a citation to the actual rule, not interpretation

Yes, exactly this, and it is the bit that took me 66 weeks to accept.

replysharereportpermalink
u/blunt_coldbox_notes23 points·1 year ago

Not to be pedantic but API source and shortage list are being used interchangeably and they are not interchangeable in real life.

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.